Clarize M. de Korne

Leiden University Medical Center

Papers

4

Total Citations

60

H-Index

3

About

Clarize M. de Korne is a translational researcher at the forefront of surgical oncology, specializing in image-guided interventions for urologic and hepatobiliary cancers. Her work centers on improving surgical precision through advanced tracer technologies and predictive modeling. De Korne’s major contributions include pioneering the use of bimodal tracers like <i>h</i>HEPATO-Cy5 for hepatobiliary surgery, enabling fluorescence-guided resection of deep liver lesions (3 citations). In prostate cancer, she led a landmark phase II trial comparing intratumoral versus intraprostatic tracer injection for sentinel node detection, demonstrating that drainage pathways significantly impact nodal metastasis detection (31 citations). Her predictive models for erectile dysfunction after nerve-sparing robot-assisted radical prostatectomy, incorporating fascia preservation extent and thickness, provide surgeons with actionable intraoperative guidance (17 and 9 citations). With a growing citation impact across her portfolio, de Korne’s work bridges the gap between imaging innovation and clinical outcomes, offering tangible improvements in cancer surgery. Her research is particularly notable for its direct translational potential, shaping how surgeons approach complex resections and nerve-sparing techniques.

Research Focus

Key Achievements

3
H-Index
4
Papers
60
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
The impact of drainage pathways on the detection of nodal metastases in prostate cancer: a phase II randomized comparison of intratumoral vs intraprostatic tracer injection for sentinel node detection
31 citations · 2021
📈 Most Prolific Year: 2018 (2 Papers)
🤝 Key Collaborators: 27
🏛 Institutions: Leiden University Medical Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago